Origins of the tumor microenvironment: quantitative assessment of adipose-derived and bone marrow-derived stroma
Open accessThe DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Abstract
To meet the requirements for rapid tumor growth, a complex array of non-neoplastic cells are recruited to the tumor microenvironment. These cells facilitate tumor development by providing matrices, cytokines, growth factors, as well as vascular networks for nutrient and waste exchange, however their precise origins remain unclear. Through multicolored tissue transplant procedures; we have quantitatively determined the contribution of bone marrow-derived and adipose-derived cells to stromal populations within syngeneic ovarian and breast murine tumors. Our results indicate that subpopulations of tumor-associated fibroblasts (TAFs) are recruited from two distinct sources. The majority of fibroblast specific protein (FSP) positive and fibroblast activation protein (FAP) positive TAFs originate from mesenchymal stem/stromal cells (MSC) located in bone marrow sources, whereas most vascular and fibrovascular stroma (pericytes, α-SMA(+) myofibroblasts, and endothelial cells) originates from neighboring adipose tissue. These results highlight the capacity for tumors to utilize multiple sources of structural cells in a systematic and discriminative manner.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“MSC can be mobilized and recruited to active tumor sites, where they can incorporate into the tumor’s microenvironment [5, 68, 100–103].”
From Mesenchymal stem cell secretome and regenerative therapy after cancer (2013) · cites this paper as [68]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation of Putative Progenitor Endothelial Cells for Angiogenesis
Asahara, T., Murohara, T., Sullivan, A., Silver, M., van der Zee, R., Li, T., Witzenbichler, B., Schatteman, G., & Isner, J. M. (1997) · Science · doi:10.1126/science.275.5302.964 · Cited by 8,725 · cited 1×
“The existence of a circulating bone marrow-derived endothelial progenitor (BM EPC) has been a topic of controversy for the past decade, dating back to its initial description by Asahara and colleagues in 1997 [39].”
BackgroundMultilineage Cells from Human Adipose Tissue: Implications for Cell-Based Therapies
Zuk, P. A., Zhu, M., Mizuno, H., Huang, J., Futrell, J. W., Katz, A. J., Benhaim, P., Lorenz, H. P., & Hedrick, M. H. (2001) · Tissue Engineering · doi:10.1089/107632701300062859 · Cited by 7,956 · cited 1×
“Within the stromal fraction of WAT, progenitors with a similar phenotype, proliferative rate and differential capacity to BM MSC have been identified [47,54].”
BackgroundOverweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. Adults
Calle, E. E., Rodriguez, C., Walker-Thurmond, K., & Thun, M. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021423 · Cited by 7,696 · cited 1×
“Obesity has been determined as a predisposing factor for cancer development and is associated with poor prognosis of certain cancer types [50].”
BackgroundKern, S., Eichler, H., Stoeve, J., Klüter, H., & Bieback, K. (2006) · STEM CELLS · doi:10.1634/stemcells.2005-0342 · Cited by 3,370
Asahara, T., Masuda, H., Takahashi, T., Kalka, C., Pastore, C., Silver, M., Kearne, M., Magner, M., & Isner, J. M. (1999) · Circulation Research · doi:10.1161/01.res.85.3.221 · Cited by 3,253 · cited 2×
“BM EPC have been reported to contribute significantly to tumor vasculature in many investigations [6,32,33].”
BackgroundAdipose-derived stem cells for regenerative medicine
Gimble, J. M., Katz, A. J., & Bunnell, B. A. (2007) · Circulation Research · doi:10.1161/01.res.0000265074.83288.09 · Cited by 2,332 · cited 1×
“Within the stromal fraction of WAT, progenitors with a similar phenotype, proliferative rate and differential capacity to BM MSC have been identified [47,54].”
BackgroundDistinct role of macrophages in different tumor microenvironments
Lewis, C. E., & Pollard, J. W. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4005 · Cited by 2,225
Lyden, D., Hattori, K., Dias, S., Costa, C., Blaikie, P., Butros, L., Chadburn, A., Heissig, B., Marks, W., Witte, L., et al. (2001) · Nature Medicine · doi:10.1038/nm1101-1194 · Cited by 1,860 · cited 2×
“BM EPC have been reported to contribute significantly to tumor vasculature in many investigations [6,32,33].”
BackgroundDeNardo, D. G., Brennan, D. J., Rexhepaj, E., Ruffell, B., Shiao, S. L., Madden, S. F., Gallagher, W. M., Wadhwani, N., Keil, S. D., Junaid, S. A., et al. (2011) · Cancer Discovery · doi:10.1158/2159-8274.cd-10-0028 · Cited by 1,715
De Palma, M., Venneri, M. A., Galli, R., Sergi, L. S., Politi, L. S., Sampaolesi, M., & Naldini, L. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.08.002 · Cited by 1,311
Quante, M., Tu, S. P., Tomita, H., Gonda, T., Wang, S. S. W., Takashi, S., Baik, G. H., Shibata, W., DiPrete, B., Betz, K. S., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.01.020 · Cited by 1,044 · cited 4×
“Furthermore, several studies have addressed the contribution of bone marrow derived cells to the tumor microenvironment utilizing transgenic mouse models [9], and human bone marrow transplant patient tumor samples [10].”
BackgroundMethodResultInfluentialNozawa, H., Chiu, C., & Hanahan, D. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601807103 · Cited by 923
Carcinoma-associated fibroblast-like differentiation of human mesenchymal stem cells
Mishra, P. J., Mishra, P. J., Humeniuk, R., Medina, D. J., Alexe, G., Mesirov, J. P., Ganesan, S., Glod, J. W., & Banerjee, D. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0943 · Cited by 912 · cited 1×
“While a-SMA, NG2, FAP, and FSP have often been grouped together as collective markers for TAF and/or myofibroblasts [7,27,29], in this work it is apparent these markers designate disparate mesenchyme populations with distinct tissues of origin.”
BackgroundTraktuev, D. O., Merfeld-Clauss, S., Li, J., Kolonin, M., Arap, W., Pasqualini, R., Johnstone, B. H., & March, K. L. (2008) · Circulation Research · doi:10.1161/circresaha.107.159475 · Cited by 839 · cited 1×
“Precursors from WAT have been shown to contribute to in vitro vessel formation and stabilization [48] as well as in vivo revascularization of damaged skeletal muscle [53].”
BackgroundSpaeth, E. L., Dembinski, J. L., Sasser, A. K., Watson, K., Klopp, A., Hall, B., Andreeff, M., & Marini, F. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004992 · Cited by 807 · cited 3×
“Varying reports in the literature have indicated conflicting data concerning the origins of tumor associated stromal cells [1,7,15,20,25,57,58].”
BackgroundResultSelf-citationThe biology of white adipocyte proliferation
Hausman, D. B., DiGirolamo, M., Bartness, T. J., Hausman, G. J., & Martin, R. J. (2001) · Obesity Reviews · doi:10.1046/j.1467-789x.2001.00042.x · Cited by 707 · cited 2×
“Additionally, this tissue readily expands, perhaps providing new potential MSC niches [49].”
BackgroundBeneficial Effects of Subcutaneous Fat Transplantation on Metabolism
Tran, T. T., Yamamoto, Y., Gesta, S., & Kahn, C. R. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.04.004 · Cited by 703 · cited 2×
“Adipose tissue transplants were performed as described previously [55].”
BackgroundIdentification of fibroblast heterogeneity in the tumor microenvironment
Sugimoto, H., Mundel, T. M., Kieran, M. W., & Kalluri, R. (2006) · Cancer Biology & Therapy · doi:10.4161/cbt.5.12.3354 · Cited by 699 · cited 2×
“Though TAFs have been collectively grouped under the same generic nomenclature, our results as well as the results of others [34] indicate this is a heterogeneous population with discreet subpopulations.”
BackgroundResultKidd, S., Spaeth, E., Dembinski, J. L., Dietrich, M., Watson, K., Klopp, A., Battula, V. L., Weil, M., Andreeff, M., & Marini, F. C. (2009) · Stem Cells · doi:10.1002/stem.187 · Cited by 679 · cited 2×
“In addition, our group recently demonstrated that bone marrow derived mesenchyme contributes to vascular and fibroblastic structures within the tumor microenvironment [7,14].”
BackgroundMethodSelf-citationDevelopment of a Syngeneic Mouse Model for Events Related to Ovarian Cancer
Roby, K. F., Taylor, C. C., Sweetwood, J. P., Cheng, Y., Pace, J. L., Tawfik, O., Persons, D. L., Smith, P. G., & Terranova, P. F. (2000) · Carcinogenesis · doi:10.1093/carcin/21.4.585 · Cited by 593 · cited 2×
“Cell Culture ID8 C57Bl/6 murine ovarian tumor cells were a generous gift of Dr. Kathy Roby (University of Kansas Medicial Center) [59].”
BackgroundDe Palma, M., Venneri, M. A., Roca, C., & Naldini, L. (2003) · Nature Medicine · doi:10.1038/nm871 · Cited by 549 · cited 1×
“However, other studies have revealed no contribution of the bone marrow to neovasculature in tumors [18,24,40,41].”
BackgroundSong, S., Ewald, A. J., Stallcup, W., Werb, Z., & Bergers, G. (2005) · Nature Cell Biology · doi:10.1038/ncb1288 · Cited by 548
Bone marrow contribution to tumor-associated myofibroblasts and fibroblasts
Direkze, N. C., Hodivala-Dilke, K., Jeffery, R., Hunt, T., Poulsom, R., Oukrif, D., Alison, M. R., & Wright, N. A. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1708 · Cited by 530 · cited 2×
“Varying reports in the literature have indicated conflicting data concerning the origins of tumor associated stromal cells [1,7,15,20,25,57,58].”
BackgroundResultRebelatto, C. K., Aguiar, A. M., Moretão, M. P., Senegaglia, A. C., Hansen, P., Barchiki, F., Oliveira, J., Martins, J., Kuligovski, C., Mansur, F., et al. (2008) · Experimental Biology and Medicine · doi:10.3181/0712-rm-356 · Cited by 429
Rajantie, I., Ilmonen, M., Alminaite, A., Ozerdem, U., Alitalo, K., & Salven, P. (2004) · Blood · doi:10.1182/blood-2004-01-0336 · Cited by 390
Migratory neighbors and distant invaders: tumor-associated niche cells
Wels, J., Kaplan, R. N., Rafii, S., & Lyden, D. (2008) · Genes & Development · doi:10.1101/gad.1636908 · Cited by 381 · cited 1×
“Varying reports in the literature have indicated conflicting data concerning the origins of tumor associated stromal cells [1,7,15,20,25,57,58].”
ResultZhang, Y., Daquinag, A., Traktuev, D. O., Amaya-Manzanares, F., Simmons, P. J., March, K. L., Pasqualini, R., Arap, W., & Kolonin, M. G. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3444 · Cited by 331 · cited 3×
“Additionally, adipose tissue transplanted in a nude mouse was shown to be recruited to developing tumors 2cm away from the fat location [4,8].”
BackgroundTissue-resident stem cells promote breast cancer growth and metastasis
Muehlberg, F. L., Song, Y.-H., Krohn, A., Pinilla, S. P., Droll, L. H., Leng, X., Seidensticker, M., Ricke, J., Altman, A. M., Devarajan, E., et al. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp036 · Cited by 330
Göthert, J. R., Gustin, S. E., van Eekelen, J. A. M., Schmidt, U., Hall, M. A., Jane, S. M., Green, A. R., Göttgens, B., Izon, D. J., & Begley, C. G. (2004) · Blood · doi:10.1182/blood-2003-11-3952 · Cited by 285 · cited 1×
“However, other studies have revealed no contribution of the bone marrow to neovasculature in tumors [18,24,40,41].”
BackgroundBone-marrow-derived myofibroblasts contribute to the cancer-induced stromal reaction
Ishii, G., Sangai, T., Oda, T., Aoyagi, Y., Hasebe, T., Kanomata, N., Endoh, Y., Okumura, C., Okuhara, Y., Magae, J., et al. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)01544-4 · Cited by 281 · cited 2×
“BM EPC have been reported to contribute significantly to tumor vasculature in many investigations [6,32,33].”
BackgroundThe metastasis associated protein S100A4: role in tumour progression and metastasis
Helfman, D. M., Kim, E. J., Lukanidin, E., & Grigorian, M. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602613 · Cited by 236
Goon, P. K. Y., Lip, G. Y. H., Boos, C. J., Stonelake, P. S., & Blann, A. D. (2006) · Neoplasia · doi:10.1593/neo.05592 · Cited by 217
Kidd, S., Caldwell, L., Dietrich, M., Samudio, I., Spaeth, E. L., Watson, K., Shi, Y., Abbruzzese, J., Konopleva, M., Andreeff, M., et al. (2010) · Cytotherapy · doi:10.3109/14653241003631815 · Cited by 201 · cited 1×
“BM-MSC have been well characterized for their tropism for inflammatory microenvironments such as wounded tissue and tumors [30].”
BackgroundSelf-citationWang, X. M., Yu, D. M. T., McCaughan, G. W., & Gorrell, M. D. (2005) · Hepatology · doi:10.1002/hep.20853 · Cited by 193
Schneider, M., Hansen, J. L., & Sheikh, S. P. (2008) · Journal of Molecular Medicine · doi:10.1007/s00109-007-0301-3 · Cited by 173
Molecular regulation of pancreatic stellate cell function.
Jaster, R. (2004) · Molecular Cancer · doi:10.1186/1476-4598-3-26 · Cited by 173 · cited 1×
“Additionally, studies focusing on fibrosis leading to cancer development have identified activated tissue resident cells responsible for excessive extracellular matrix (ECM) production, such as pancreatic stellate cells in pancreatitis that induce progression to pancreatic cancer [2] or peribronchiolar and perivascula…”
BackgroundAdiposity, the Metabolic Syndrome, and Breast Cancer in African-American and White American Women
Rose, D. P., Haffner, S. M., & Baillargeon, J. (2007) · Endocrine Reviews · doi:10.1210/er.2006-0019 · Cited by 166 · cited 1×
“from overgrowth of white adipose tissue (WAT), it has been proposed that this tissue may play a significant role in tumor initiation and/or progression [4,51,52].”
BackgroundObesity is associated with increased levels of circulating hepatocyte growth factor
Rehman, J., Considine, R. V., Bovenkerk, J. E., Li, J., Slavens, C. A., Jones, R. M., & March, K. L. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00231-6 · Cited by 162 · cited 1×
“from overgrowth of white adipose tissue (WAT), it has been proposed that this tissue may play a significant role in tumor initiation and/or progression [4,51,52].”
BackgroundObesity in the United States: A Fresh Look at Its High Toll
Manson, J. E., & Bassuk, S. S. (2003) · JAMA · doi:10.1001/jama.289.2.229 · Cited by 161 · cited 1×
“are classified as overweight or obese [56].”
Monsky, W. L., Carreira, C. M., Tsuzuki, Y., Gohongi, T., Fukumura, D., & Jain, R. K. (2002) · PubMed · Cited by 161
Kunz‐Schughart, L. A., & Knuechel, R. (2002) · PubMed · doi:10.14670/hh-17.599 · Cited by 161 · cited 1×
“While a-SMA, NG2, FAP, and FSP have often been grouped together as collective markers for TAF and/or myofibroblasts [7,27,29], in this work it is apparent these markers designate disparate mesenchyme populations with distinct tissues of origin.”
BackgroundDuffy, G. P., Ahsan, T., O’Brien, T., Barry, F., & Nerem, R. M. (2009) · Tissue Engineering Part A · doi:10.1089/ten.tea.2008.0341 · Cited by 158 · cited 1×
“Varying reports in the literature have indicated conflicting data concerning the origins of tumor associated stromal cells [1,7,15,20,25,57,58].”
ResultThe Extrapulmonary Origin of Fibroblasts: Stem/Progenitor Cells and Beyond
Lama, V. N., & Phan, S. H. (2006) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200512-133tk · Cited by 151 · cited 1×
“Additionally, studies focusing on fibrosis leading to cancer development have identified activated tissue resident cells responsible for excessive extracellular matrix (ECM) production, such as pancreatic stellate cells in pancreatitis that induce progression to pancreatic cancer [2] or peribronchiolar and perivascula…”
BackgroundThe bone marrow constitutes a reservoir of pericyte progenitors
Lamagna, C., & Bergers, G. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.0506309 · Cited by 131
Nishitani, Y., Iwano, M., Yamaguchi, Y., Harada, K., Nakatani, K., Akai, Y., Nishino, T., Shiiki, H., Kanauchi, M., Saito, Y., et al. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00500.x · Cited by 101 · cited 1×
“Corresponding distinctions between FSP and a-SMA expression have also been noted in examinations of fibrotic glomerulonephritis [35].”
BackgroundProspective Isolation of Mesenchymal Stem Cells from Mouse Compact Bone
Short, B. J., Brouard, N., & Simmons, P. J. (2009) · Methods in Molecular Biology · doi:10.1007/978-1-59745-060-7_16 · Cited by 85 · cited 3×
“to contain all MSC activity from the bone marrow [31].”
BackgroundMethodInfluentialHutchinson, L., Stenström, B., Chen, D., Piperdi, B., Levey, S., Lyle, S. R., Wang, T. C., & Houghton, J. (2010) · Stem Cells and Development · doi:10.1089/scd.2010.0139 · Cited by 81 · cited 1×
“Furthermore, several studies have addressed the contribution of bone marrow derived cells to the tumor microenvironment utilizing transgenic mouse models [9], and human bone marrow transplant patient tumor samples [10].”
BackgroundGrenier, G., Scimè, A., Le Grand, F., Asakura, A., Perez-Iratxeta, C., Andrade-Navarro, M. A., Labosky, P. A., & Rudnicki, M. A. (2007) · Stem Cells · doi:10.1634/stemcells.2006-0795 · Cited by 78 · cited 1×
“Precursors from WAT have been shown to contribute to in vitro vessel formation and stabilization [48] as well as in vivo revascularization of damaged skeletal muscle [53].”
BackgroundMinimal Contribution of Marrow-Derived Endothelial Precursors to Tumor Vasculature
Larrivée, B., Niessen, K. S., Pollet, I. L., Corbel, S. Y., Long, M., Rossi, F. M. V., Olive, P. L., & Karsan, A. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.5.2890 · Cited by 77 · cited 1×
“However, other studies have revealed no contribution of the bone marrow to neovasculature in tumors [18,24,40,41].”
BackgroundDöme, B., Tímár, J., Ladányi, A., Paku, S., Renyi-Vamos, F., Klepetko, W., Láng, G., Döme, P., Bogos, K., & Tóvári, J. (2008) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2008.06.009 · Cited by 73 · cited 1×
“Varying reports in the literature have indicated conflicting data concerning the origins of tumor associated stromal cells [1,7,15,20,25,57,58].”
ResultUdagawa, T., Puder, M., Wood, M., Schaefer, B. C., & D'Amato, R. J. (2006) · The FASEB Journal · doi:10.1096/fj.04-3669com · Cited by 69 · cited 4×
“Varying reports in the literature have indicated conflicting data concerning the origins of tumor associated stromal cells [1,7,15,20,25,57,58].”
BackgroundResultInfluentialSangai, T., Ishii, G., Kodama, K., Miyamoto, S., Aoyagi, Y., Ito, T., Magae, J., Sasaki, H., Nagashima, T., Miyazaki, M., et al. (2005) · International Journal of Cancer · doi:10.1002/ijc.20969 · Cited by 68
Bartsch, K., Al‐Ali, H. K., Reinhardt, A., Franke, C., Hudecek, M., Kamprad, M., Tschiedel, S., Cross, M. A., Niederwieser, D. W., & Gentilini, C. (2009) · Transplantation · doi:10.1097/tp.0b013e3181938998 · Cited by 66
Hematopoietic Stem Cell–Derived Pericytic Cells in Brain Tumor Angio-Architecture
Bababeygy, S. R., Cheshier, S. H., Hou, L. C., Higgins, D. M. O., Weissman, I. L., & Tse, V. C. K. (2008) · Stem Cells and Development · doi:10.1089/scd.2007.0117 · Cited by 58
Slominski, A. T., Roloff, B., Zbytek, B., Wei, E. T., Fechner, K., Curry, J. L., & Wortsman, J. (2000) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1290/1071-2690(2000)036<0201:ahsemt>2.0.co;2 · Cited by 56
Dickhut, A., Schwerdtfeger, R., Kuklick, L., Ritter, M., Thiede, C., Neubauer, A., & Brendel, C. A. (2005) · Annals of Hematology · doi:10.1007/s00277-005-1067-8 · Cited by 52 · cited 1×
“Since MSC are resistant to radiation, as evidenced by their persistence after a lethal dose in our hands and previous reports [43,44], these cells are still occupying the bone marrow MSC niche, and transplanted MSC may not have a place to engraft within that environment.”
BackgroundEmura, M., Ochiai, A., Horino, M., Arndt, W., Kamino, K., & Hirohashi, S. (2000) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1290/1071-2690(2000)036<0077:domfhb>2.0.co;2 · Cited by 51
Reddy, K., Zhou, Z., Schadler, K., Jia, S.-F., & Kleinerman, E. S. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-07-2189 · Cited by 48 · cited 1×
“Varying reports in the literature have indicated conflicting data concerning the origins of tumor associated stromal cells [1,7,15,20,25,57,58].”
ResultIshii, G., Sangai, T., Ito, T., Hasebe, T., Endoh, Y., Sasaki, H., Harigaya, K., & Ochiai, A. (2005) · International Journal of Cancer · doi:10.1002/ijc.21199 · Cited by 42
Research works printed but not linked: 1
- M Studeny, 2001, Bone marrow derived mesenchymal stem cells serve as precursors for stromal fibroblasts in malignant tumors and show potential for cancer therapy., Blood, 9, 697a
Cited by
The Tumour Microenvironment after Radiotherapy: Mechanisms of Resistance and Recurrence
Barker, H. E., Paget, J. T. E., Khan, A. A., & Harrington, K. J. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3958 · Cited by 2,144
Diversity and biology of cancer-associated fibroblasts
Biffi, G., & Tuveson, D. A. (2021) · Physiological Reviews · doi:10.1152/physrev.00048.2019 · Cited by 1,265
Fibroblast heterogeneity in the cancer wound
Öhlund, D., Elyada, E., & Tuveson, D. (2014) · Journal of Experimental Medicine · doi:10.1084/jem.20140692 · Cited by 926
Bresnick, A. R., Weber, D. J., & Zimmer, D. B. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3893 · Cited by 822
The myofibroblast matrix: implications for tissue repair and fibrosis
Klingberg, F., Hinz, B., & White, E. S. (2013) · The Journal of Pathology · doi:10.1002/path.4104 · Cited by 776
“A number of recent reviews have considered the nature of myofibroblastprogenitors in different organs [21], including resident fibroblasts [3,19,22-25], fibrocytes[26-28],smooth muscle cells [29], pericytes[30-33], epithelial and endothelial cells undergoing endothelial (EndoMT) or epithelial-to-mesenchymal transition…”
Metadata
- Authors
- Kidd, S., Spaeth, E., Watson, K., Burks, J., Lu, H., Klopp, A., Andreeff, M., & Marini, F. C.
- Affiliations
- The University of Texas MD Anderson Cancer Center (US)
- Corresponding author
- Marini, Frank C.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-02-20
- Volume
- 7
- Issue
- 2
- Pages
- e30563
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3282707
- OpenAlex
- W1972938311
- Cited by
- 371
- References
- 58
- Citations by year
- 2026: 4 · 2025: 9 · 2024: 19 · 2023: 32 · 2022: 24 · 2021: 30 · 2020: 23 · 2019: 29 · 2018: 22 · 2017: 21 · 2016: 30 · 2015: 32 · 2014: 34 · 2013: 44 · 2012: 18
- FWCI
- 20.24
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Funders
- U.S. Department of Defense
- Ovarian Cancer Research Fund
- Susan G. Komen (BC083397)
- National Cancer Institute (P50CA116199, CA-16672, CA-55164, R01CA109451, P01CA049639, R01NS06994, P01CA055164, Ca-116199, RC1CA146381, BC083397, CA109451, P50CA083639, P30CA016672, CA 49639)
- National Institute of Neurological Disorders and Stroke (R01NS069964, R01NS06994)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Keywords
- tumor microenvironment, cancer-associated fibroblasts, mesenchymal stem cells, pericytes, myofibroblasts, endothelial cells, fibroblast activation protein, ovarian neoplasms, breast tumors, tissue transplantation
- MeSH terms
- Adipose Tissue, Animals, Bone Marrow Cells, Female, Mice, Inbred C57BL, Models, Biological, Biomarkers, Cell Line, Tumor, Green Fluorescent Proteins, Mice, Tumor Microenvironment, Mesenchymal Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.